![[Get to Know more about Multiple Sclerosis] Air pollution and multiple sclerosis risk](https://brainteaser.health/wp-content/uploads/2021/09/Brainteaser-GIFs-NewsletterWebpage-2-1080x675.jpg)
[Get to Know more about Multiple Sclerosis] Air pollution and multiple sclerosis risk
BRAINTEASER project aims to support patients with amyotrophic lateral sclerosis and multiple sclerosis and their clinicians. "Get to Know more about Multiple Sclerosis" campaign wants to bring attention to this condition and on the variables that...
BRAINTEASER: Special Session on “Artificial intelligence and statistical methods for neurodegenerative diseases” at the 17th Conference on Computational Intelligence Methods for Bioinformatics and Biostatistics (CIBB 2021)
On 15-17 November 2021, the 17th Conference on Computational Intelligence Methods for Bioinformatics and Biostatistics (CIBB 2021) will take place online. In this context, the University of Padova (Padova, Italy), member of the BRAINTEASER...
BRAINTEASER: Open co-design workshop on next generation tools to manage ALS and MS
On June 3rd took place the first open Co-design workshop of BRAINTEASER to present and discuss the digital tools that the consortium is in process of design and development. The workshop was conducted by Manuel Ottaviano (Universidad Politécnica of...
The European Brain Council launches “RETHINKING MS in times of COVID-19″ on the occasion of World Multiple Sclerosis Day
On the occasion of the World Multiple Sclerosis Day (30 May 2021), the European Brain Council (EBC), member of the BRAINTEASER Consortium, announced the release of its new policy paper, “RETHINKING MS in times of COVID-19”. This new paper is part...
BRAINTEASER first environmental sensors workshop
The Environmental Sensor workshop - organized by both technical and clinical BRAINTEASER’ partners – was aimed at discussing some crucial aspects for the development of meaningful Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS)...
BRAINTEASER online Workshops: Patients and Clinical Needs for MS and ALS
BRAINTEASER has started the co-design activities to define the system functionalities to be developed to improve the Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS)patients’ quality of life, and to support caregivers and health...
Press release
Officially started on the 1st of January 2020, the H2020 BRAINTEASER project kicked off its operational activities last week, January 28th and 29th, at the presence of its project officer Mr Tobias Wiesenthal, Head of Sector 'Research and...